TM

Tracey L. McLaughlin

Stanford University: 7 patents #291 of 5,197Top 6%
EB Eiger Biopharmaceuticals: 2 patents #5 of 11Top 50%
📍 Stanford, CA: #175 of 1,454 inventorsTop 15%
🗺 California: #60,666 of 386,348 inventorsTop 20%
Overall (All Time): #477,870 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12220444 Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39) Colleen M. Craig 2025-02-11
12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39) Colleen M. Craig 2024-10-01
11738086 Methods of using buffered formulations of exendin (9-39) Xiaofeng Xiong, Debra Odink, Colleen M. Craig, Christine Smith 2023-08-29
11622995 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists Colleen M. Craig 2023-04-11
11617782 Treatment of post-bariatric hypoglycemia with exendin (9-39) Colleen M. Craig 2023-04-04
11020484 Buffered formulations of exendin (9-39) Xiaofeng Xiong, Debra Odink, Colleen M. Craig, Christine Smith 2021-06-01
10993992 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists Colleen M. Craig 2021-05-04
10993991 Treatment of post-bariatric hypoglycemia with exendin (9-39) Colleen M. Craig 2021-05-04
10660937 Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39) Colleen M. Craig 2020-05-26
10639354 Treatment of hyperinsulinemic hypoglycemia with exendin (9-39) Colleen M. Craig 2020-05-05